Novel Technologies for Targeted Oral Peptide Delivery

11 September 2018 09:30 - 10:05

  • Therapeutic value of biologics have amplified significantly, and in the search for the best treatment regimen, the oral route has been extensively evaluated because of its non-invasive and safe nature.
  • To address the challenges originating due to the physicochemical properties of biologics and hurdles in the GI tract, several conventional and novel approaches are being used.
  • In this presentation, we will discuss the challenges to oral peptide delivery and approached used to address these challenges, with a focus on clinical level technologies.

Puneet Tyagi, Senior Scientist, AstraZeneca